1.
|
Albores-Saavedra J, Gersell D, Gilks CB,
et al: Terminology of endocrine tumors of the uterine cervix:
results of a workshop sponsored by the college of American
Pathologists and the National Cancer Institute. Arch Pathol Lab
Med. 121:34–39. 1997.
|
2.
|
Chan JK, Loizzi V, Burger RA, Rutgers J
and Monk BJ: Prognostic factors in neuroendocrine small cell
cervical carcinoma, a multivariate analysis. Cancer. 97:568–574.
2003. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Nasu K, Hirakawa T, Okamoto M, Nishida M,
Kiyoshima C, Matsumoto H, Takai N and Narahara H: Advanced small
cell carcinoma of the uterine cervix treated by neoadjuvant
chemotherapy with irinotecan and cisplatin followed by radical
surgery. Rare Tumors. 3:e62011. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Sheets EE, Berman ML, Hrountas CK, et al:
Surgically treated, early-stage neuroendocrine small-cell cervical
carcinoma. Obstet Gynecol. 71:10–14. 1988.PubMed/NCBI
|
5.
|
Reagan JW, Hamonic MJ and Wentz WB:
Analytical study of the cells in cervical squamous-cell cancer. Lab
Invest. 6:241–250. 1957.PubMed/NCBI
|
6.
|
Boruta DM 2nd, Schorge JO, Duska LA, Crum
CP, Castrillon DH and Sheets EE: Multimodality therapy in
early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol
Oncol. 81:82–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Barrett RJ 2nd, Davos I, Leuchter RS and
Lagasse LD: Neuroendocrine features in poorly differentiated and
undifferentiated carcinomas of the cervix. Cancer. 60:2325–2330.
1987. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang
KG and Chou HH: Prognostic factors in surgically treated small cell
cervical carcinoma followed by adjuvant chemotherapy. Cancer.
83:712–718. 1998. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Gilks CB, Young RH, Gersell DJ and Clement
PB: Large cell neuroendocrine carcinoma of the uterine cervix: a
clinicopathologic study of 12 cases. Am J Surg Pathol. 21:905–914.
1997. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Giorgaze T, Kanhere R, Pang C, Ganote C,
Miller LE, Tabaczka P, Brown E and Husain M: Small cell carcinoma
of the cervix in liquid-based Pap test: utilization of split-sample
immunocyto-chemical and molecular analysis. Diagn Cytopathol.
40:214–219. 2012. View
Article : Google Scholar : PubMed/NCBI
|
11.
|
Wang HL and Lu DW: Overexpression of c-kit
protein is an infrequent event in small cell carcinomas of the
uterine cervix. Mod Pathol. 17:732–738. 2004. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Sukpan K, Settakorn J, Khunamornpong S,
Cheewakriangkrai C, Srisomboon J and Siriaunkgul S: Expression of
survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the
uterine cervix. Int J Gynecol Cancer. 21:911–917. 2011. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Dueñas-Gonzalez A, López-Graniel C,
González-Enciso A, Cetina L, Rivera L, Mariscal I, Montalvo G,
Gómez E, de la Garza J, Chanona G and Mohar A: A phase II study of
multimodality treatment for locally advanced cervical cancer:
neoadjuvant carboplatin and paclitaxel followed by radical
hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol.
14:1278–1284. 2003.
|
14.
|
Bermudez A, Vighi S, Garcia A and Sardi J:
Neuroendocrine cervical carcinoma: a diagnostic and therapeutic
challenge. Gynecol Oncol. 82:32–39. 2001. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Pazdur R, Bonomi P, Slayton R, et al:
Neuroendocrine carcinoma of the cervix: implications for staging
and therapy. Gynecol Oncol. 12:120–128. 1981. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Hoskins PJ, Swenerton KD, Pike JA, et al:
Small-cell carcinoma of the cervix: fourteen years of experience at
a single institution using a combined-modality regimen of
involved-field irradiation and platinum-based combination
chemotherapy. J Clin Oncol. 21:3495–3501. 2003.
|
17.
|
Zivanovic O, Leitao MM Jr, Park KJ, et al:
Small cell neuroendocrine carcinoma of the cervix: Analysis of
outcome, recurrence pattern and the impact of platinum-based
combination chemotherapy. Gynecol Oncol. 112:590–593. 2009.
View Article : Google Scholar : PubMed/NCBI
|
18.
|
Futagami M, Yokoyama Y and Mizunuma H:
Presentation of a patient with pT2bN1M0 small cell carcinoma of the
uterine cervix who obtained long-term survival with maintenance
chemotherapy, and literature-based discussion. Eur J Gynaecol
Oncol. 32:99–102. 2011.PubMed/NCBI
|
19.
|
Embry JR, Kelly MG, Post MD and Spillman
MA: Large cell neuroendocrine carcinoma of the cervix: prognostic
factors and survival advantage with platinum chemotherapy. Gynecol
Oncol. 120:444–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Siriaunkgul S, Utaipat U, Settakorn J,
Sukpan K, Srisomboon J and Khunamornpong S: HPV genotyping in
neuroendocrine carcinoma of the uterine cervix in northern
Thailand. Int J Gynaecol Obstet. 115:175–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Bian LH, Wang XL, Guo YF, Wu XZ, Song L
and Liu HT: Study of human papillomavirus in small cell
neuroendocrine carcinoma of the uterine cervix. Chin J Exp Clin
Virol. 25:63–65. 2011.(In Chinese).
|
22.
|
Rashed MM and Bekele A: Neuroendocrine
differentiation in a case of cervical cancer. Pan Afr Med J.
6:42010.
|
23.
|
Conner MG, Richter H, Moran CA, Hameed A
and Albores-Saavedra J: Small cell carcinoma of the cervix: a
clinicopathologic and immunohistochemical study of 23 cases. Ann
Diagn Pathol. 6:345–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Deng GH, Zhang X and Wu LY:
Clinicopathological analysis of nine cases of small cell carcinoma
of the uterine cervix. Chin J Oncol. 32:199–202. 2010.(In
Chinese).
|
25.
|
Cohen JG, Kapp DS, Shin JY, Urban R,
Sherman AE, Chen LM, Osann K and Chan JK: Small cell carcinoma of
the cervix: treatment and survival outcomes of 188 patients. Am J
Obstet Gynecol. 203:3472010. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Horn LC, Fischer U and Bilek K:
Neuroendocrine differentiated carcinoma of the uterine cervix.
Zentralbl Gynakol. 118:679–683. 1996.(In German).
|